The Indian Journal of Pediatrics

, Volume 49, Issue 6, pp 823–825 | Cite as

Therapy for Advanced Hodgkin’s Disease

  • V. P. Choudhry


Vinblastine CCNU Neonatal Jaundice Monthly Cycle Arabinosyl 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    DeVita VT Jr : The consequences of the chemotherapy of Hodgkin disease; the 10th David A Karnofsky Memorial lecure. Cancer 47:_, 1981Google Scholar
  2. 2.
    Glodin A, Venditi JM, Humphreys SR, Mantel N: Quantitative evaluation of chemotherapeutic agents against advanced leukemia in mice. J Natl Cancer Inst 21 : 495, 1958Google Scholar
  3. 3.
    Skip er HE, Sehabel FM Jr, Wilcox WS: Experimental evaluation Of potential anticancer agents XIII. On the criteria and kinetics associated with ‘CurabIlity’ of experimental leukemia. Cancer Chemother Rep 35 : 3, 1964Google Scholar
  4. 4.
    Bruce WR, Meeker RE, Powers WE, Valeriote FA: Comparison of the dose and time survival Curves for normal hematopoietic and lymphoma colony forming cells exposed to vinblastine, vineristine arabinosyl cytosine and amethopterin. J Natl Cancer Inst 42 : 1015, 1969PubMedGoogle Scholar
  5. 5.
    DeVita VT Jr., Simon RM, Hubbard SM, et al: Curability of advanced Hodgkin’s disease with chemotherapy : Long term follow up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 92 : 587, 1980Google Scholar
  6. 6.
    Bonadonna G, Zucali R, Manfardini S, Delena M, Uslcnghi C: Combination Chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP. Cancer 36: 252 1975PubMedCrossRefGoogle Scholar
  7. 7.
    Santoro A, Bonfante V, Bonadonna G: Salvage Chemotherapy with ABVD in MOPP resistant Hodgkin’s disease. Ann Intern Med 96: 139, 1982PubMedGoogle Scholar
  8. 8.
    Santoro A, Bonydonna G, Bonfante V, Valagussa P: Alternating drug combinations in the treatment of advanced Hodgkin’s disease. N Engl J Med 306 : 770, 1982PubMedGoogle Scholar
  9. 9.
    Coltman CA Jr: Chemotherapy of advanced Hodgkin disease. Seminar Oncol 7:155, 1980Google Scholar
  10. 10.
    Goldie J H, Coldman AJ: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63 : 1727, 1979PubMedGoogle Scholar
  11. 11.
    Wiernik PH, Longo D, Duffey PL et al: MOPP vs MOPP alternating with streptozotocin, CCNU, adriamycin and bluomy- cin (SCAB) for advanced Hodgkin’s disease. Proc Am Assoc Cancer Res 22 : 159, 1981Google Scholar

Copyright information

© Department of Pediatrics All India Institute Of Medical Science 1982

Authors and Affiliations

  • V. P. Choudhry
    • 1
  1. 1.Hematology Division,Department of PediatricsAll India Institute of Medical SciencesNew Delhi

Personalised recommendations